Toye J M, Yang J, Sankaran K
University of Alberta, Division of Neonatology, Department of Pediatrics, Alberta, Canada.
Mount Sinai Hospital, Maternal-Infant Care Research Centre, Ontario, Canada.
J Neonatal Perinatal Med. 2019;12(2):135-141. doi: 10.3233/NPM-17157.
Mechanical ventilation (MV) causes discomfort but whether it causes pain remains controversial. Around the world neonatal intensive care units (NICU) often utilize narcotics and/or sedatives during MV of vulnerable infants yet the association with adverse neonatal outcomes has not been adequately addressed.
Test for associations between the use of narcotics/sedatives during MV and mortality/morbidity in preterm infants in a large infant cohort in Canada.
DESIGN/METHODS: Preterm infants born <35 weeks gestational age (GA) requiring MV for >24 hrs were identified retrospectively from the Canadian Neonatal Network database, 2010-12. Infants were categorized according to whether they received narcotics/sedatives for greater than 24 hours concurrently with MV. Infants were excluded if moribund on admission, had major congenital anomalies, diagnoses where narcotic administration is routine and suspected seizures. Multivariable logistic and linear regression analysis tested for association of narcotics/sedatives use during MV with mortality/morbidity (nosocomial infections, BPD, ROP, IVH) and length of MV.
After exclusions the cohort included 2672 infants; 467(17%) exposed only to narcotics 101(4%) only to sedatives and 299(11%) to both. All models were adjusted for GA, gender, small for GA, SNAP-II score >20, multiple births, delivery mode, outborn, PDA status, MV type, use of high flow, muscle relaxant use, indwelling lines, caffeine and surfactant therapy. The composite mortality/morbidity, and MV days were significantly higher for MV infants exposed to narcotics, sedatives or both compared to infants not exposed.
Mounting evidence of the adverse short and long-term impacts of narcotics/sedatives during MV supports the need for further work in alternative therapies.
机械通气(MV)会引起不适,但它是否会导致疼痛仍存在争议。在全球范围内,新生儿重症监护病房(NICU)在对脆弱婴儿进行机械通气时经常使用麻醉剂和/或镇静剂,但与新生儿不良结局的关联尚未得到充分研究。
在加拿大一个大型婴儿队列中,测试机械通气期间使用麻醉剂/镇静剂与早产儿死亡率/发病率之间的关联。
设计/方法:回顾性分析2010 - 2012年加拿大新生儿网络数据库中孕周小于35周(GA)且需要机械通气超过24小时的早产儿。根据婴儿在机械通气期间是否同时接受麻醉剂/镇静剂超过24小时进行分类。如果婴儿入院时濒死、有重大先天性异常、麻醉剂给药为常规操作的诊断以及疑似癫痫,则将其排除。多变量逻辑回归和线性回归分析测试了机械通气期间使用麻醉剂/镇静剂与死亡率/发病率(医院感染、支气管肺发育不良、早产儿视网膜病变、脑室内出血)以及机械通气时长之间的关联。
排除后,队列包括2672名婴儿;467名(17%)仅暴露于麻醉剂,101名(4%)仅暴露于镇静剂,299名(11%)同时暴露于两者。所有模型均根据孕周、性别、小于胎龄儿、SNAP-II评分>20、多胎妊娠、分娩方式、院外出生、动脉导管未闭状态、机械通气类型、高流量使用、肌肉松弛剂使用、留置管路、咖啡因和表面活性剂治疗进行了调整。与未暴露的婴儿相比,暴露于麻醉剂、镇静剂或两者的机械通气婴儿的综合死亡率/发病率以及机械通气天数显著更高。
越来越多的证据表明,机械通气期间使用麻醉剂/镇静剂会产生短期和长期不良影响,这支持了对替代疗法进行进一步研究的必要性。